Gyroscope Therapeutics Holdings plc risk profile

67 Stretched several inputs deteriorating together

Measured 1 September 2026 from VISN's filed statements. Recomputed nightly.

67 (Stretched), driven by Market expectation at 76, over 4 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation76StretchedVolatileOne-year price volatility — 83.5%
Operating pressureReads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company.
Cash conversion42ElevatedWorseningCash conversion — 0.14x
Leverage and coverage73StretchedEasingNet debt to EBITDA — 20.04x
Competitive position70StretchedStableRevenue-growth gap against peers — -87.9 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Technology companies with a risk reading

Financials, valuation and price history for Gyroscope Therapeutics Holdings plc